‘Genuine hope’ for COPD patients as new jab is rolled out on NHS
The NHS has begun rolling out a new injection called dupilumab for patients suffering from chronic obstructive pulmonary disorder (COPD). The treatment aims to reduce inflammation and improve quality of life for thousands of patients.
Why it matters
This represents a significant medical advancement for a debilitating condition that currently lacks highly effective long-term treatments.
A revolutionary injection for chronic obstructive pulmonary disorder (COPD) is being rolled out on the NHS . The jab tackles the inflammation driving symptoms and could benefit up to 30,000 people with the debilitating lung condition. Patrick Regan, 67, was the first patient to receive the drug, dupilumab, at St Thomas’ Hospital in London .
The article provides a factual report on a new medical treatment and its impact on patients.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in